BACKGROUND AND OBJECTIVES: Many disposable platforms have been applied in laparoendoscopic single-site surgery (LESS). Besides technical issues, cost is one of the limiting factors for its widespread acceptance. The current study describes the first completely reusable LESS-platform. METHODS: We performed LESS-procedures in 52 patients including nephrectomy (18), adrenalectomy (2), partial nephrectomy (3), pyeloplasty (4), renal cyst ablation (4), pelvic lymphadenectomy (15), and lymphocele ablation (6). All procedures were conducted using a novel reusable single-port device (X-Cone, Karl-Storz) with a simplified set of instruments. We obtained perioperative and demographic data, including a visual analogue pain scale (VAS), and a complication reporting system based on Clavien grading. RESULTS: Mean age was 50.04 y. Conversion to standard laparoscopy was necessary in 3 cases and addition of a needlescopic instrument in 6 cases. There was no open conversion. Intra- and postoperative complications occurred in 3 (Clavien II in 2 and III in 1) cases. Mean operative time was 110, 90, and 89 min, and hospital stay was 4.9, 3.1, and 3.6 d for nephrectomy, pelvic lymphadenectomy, and pyeloplasty, respectively. Mean VAS was 2.13, 1.07, and 1.5 while blood loss was 81.3 mL, 25.67 mL, and 17.5 mL, respectively. Mean lymph node yield was 15 (range, 8 to 21). CONCLUSIONS: A completely reusable LESS-platform is applicable to various uses in urology, yielding favorable functional and cosmetic results. Reusable materials are useful to reduce the cost of LESS, further increasing its acceptance. LESS with a completely reusable platform is more cost effective than standard laparoscopy.
BACKGROUND AND OBJECTIVES: Many disposable platforms have been applied in laparoendoscopic single-site surgery (LESS). Besides technical issues, cost is one of the limiting factors for its widespread acceptance. The current study describes the first completely reusable LESS-platform. METHODS: We performed LESS-procedures in 52 patients including nephrectomy (18), adrenalectomy (2), partial nephrectomy (3), pyeloplasty (4), renal cyst ablation (4), pelvic lymphadenectomy (15), and lymphocele ablation (6). All procedures were conducted using a novel reusable single-port device (X-Cone, Karl-Storz) with a simplified set of instruments. We obtained perioperative and demographic data, including a visual analogue pain scale (VAS), and a complication reporting system based on Clavien grading. RESULTS: Mean age was 50.04 y. Conversion to standard laparoscopy was necessary in 3 cases and addition of a needlescopic instrument in 6 cases. There was no open conversion. Intra- and postoperative complications occurred in 3 (Clavien II in 2 and III in 1) cases. Mean operative time was 110, 90, and 89 min, and hospital stay was 4.9, 3.1, and 3.6 d for nephrectomy, pelvic lymphadenectomy, and pyeloplasty, respectively. Mean VAS was 2.13, 1.07, and 1.5 while blood loss was 81.3 mL, 25.67 mL, and 17.5 mL, respectively. Mean lymph node yield was 15 (range, 8 to 21). CONCLUSIONS: A completely reusable LESS-platform is applicable to various uses in urology, yielding favorable functional and cosmetic results. Reusable materials are useful to reduce the cost of LESS, further increasing its acceptance. LESS with a completely reusable platform is more cost effective than standard laparoscopy.
Authors: Lesli I Nicolay; Ryan J Bowman; Jonathan P Heldt; Forrest C Jellison; Neda Mehr; Christopher Tenggardjaja; William Millard; Jeffrey L Koning; D Duane Baldwin Journal: J Endourol Date: 2011-06-01 Impact factor: 2.942
Authors: Inderbir S Gill; Arnold P Advincula; Monish Aron; Jeffrey Caddedu; David Canes; Paul G Curcillo; Mihir M Desai; John C Evanko; Tomasso Falcone; Victor Fazio; Matthew Gettman; Andrew A Gumbs; Georges-Pascal Haber; Jihad H Kaouk; Fernando Kim; Stephanie A King; Jeffrey Ponsky; Feza Remzi; Homero Rivas; Alexander Rosemurgy; Sharona Ross; Philip Schauer; Rene Sotelo; Jose Speranza; John Sweeney; Julio Teixeira Journal: Surg Endosc Date: 2009-12-09 Impact factor: 4.584
Authors: David Canes; Andre Berger; Monish Aron; Ricardo Brandina; David A Goldfarb; Daniel Shoskes; Mihir M Desai; Inderbir S Gill Journal: Eur Urol Date: 2009-07-28 Impact factor: 20.096
Authors: Mihir M Desai; Monish Aron; David Canes; Khaled Fareed; Oswaldo Carmona; Georges-Pascal Haber; Sebastien Crouzet; Juan Carlos Astigueta; Roy Lopez; Robert de Andrade; Robert J Stein; James Ulchaker; Rene Sotelo; Inderbir S Gill Journal: Urology Date: 2008-10-04 Impact factor: 2.649
Authors: Frank Friedersdorff; Seven Johannes Aghdassi; Ahmed Magheli; Maximilian Richter; Carsten Stephan; Jonas Busch; Dirk Boehmer; Kurt Miller; T Florian Fuller Journal: BMC Urol Date: 2014-11-21 Impact factor: 2.264